You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

~ Buy the RELYVRIO (sodium phenylbutyrate; taurursodiol) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR RELYVRIO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for RELYVRIO

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05619783 ↗	Extension Study Evaluating The Safety And Tolerability of AMX0035	Not yet recruiting	Amylyx Pharmaceuticals Inc.	Phase 3	2022-11-01	The primary objective is to evaluate the safety and tolerability of AMX0035 over 108 weeks of open label treatment for participants previously enrolled in Study A35-004 (PHOENIX).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RELYVRIO

Condition Name

Chart
Table

Condition Name for RELYVRIO
Intervention	Trials
Amyotrophic Lateral Sclerosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RELYVRIO
Intervention	Trials
Sclerosis	1
Motor Neuron Disease	1
Amyotrophic Lateral Sclerosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RELYVRIO

Trials by Country

Map
Table

Trials by Country for RELYVRIO
Location	Trials
Belgium	1
Ireland	1
Poland	1
Sweden	1
Germany	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RELYVRIO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RELYVRIO
Clinical Trial Phase	Trials
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RELYVRIO
Clinical Trial Phase	Trials
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RELYVRIO

Sponsor Name

Chart
Table

Sponsor Name for RELYVRIO
Sponsor	Trials
Amylyx Pharmaceuticals Inc.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RELYVRIO
Sponsor	Trials
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.